Search results
Results from the WOW.Com Content Network
Sveriges riksdags health ministry Statens folkhälsoinstitut classified 5-MeO-DiPT as "health hazard" under the act Lagen om förbud mot vissa hälsofarliga varor (translated Act on the Prohibition of Certain Goods Dangerous to Health) as of Oct 1, 2004, in their regulation SFS 2004:696 listed as 5-metoxi-N,N-diisopropyltryptamin (5-MeO-DIPT), making it illegal to sell or possess.
Little is known about the subjective effects of 5-MeO-DPT, but the nature of the compound is probably comparable to 5-MeO-DiPT, 5-MeO-DMT, or DPT, which are also psychedelic tryptamines/indoles. However, the duration of the above-mentioned drugs vary considerably.
5-MeO-DBT (5-Methoxy-N,N-dibutyltryptamine, 5-MeO-BET) is a rare substituted tryptamine derivative, which is thought to be a psychoactive substance and was identified in a designer drug sample by a forensic laboratory in Slovenia in March 2021, [1] although only analytical studies have been conducted and no pharmacological data is available.
5-MeO-DET inhibits serotonin reuptake with an IC 50 value of 2.4 μM and activates 5-HT 2A receptors with an EC 50 value of 8.11 nM. [1 ... 5-MeO-DiPT; 5-MeO-DMT; 5 ...
3,4-Methylenedioxy-N-ethylamphetamine (MDEA; also called MDE and colloquially, Eve) is an empathogenic psychoactive drug. MDEA is a substituted amphetamine and a substituted methylenedioxyphenethylamine. MDEA acts as a serotonin, norepinephrine, and dopamine releasing agent and reuptake inhibitor. [1] Possession of MDEA is illegal in most ...
5-MeO-EPT is a psychedelic tryptamine derivative which has been sold as a designer drug. [1] [2] Legality. 5-MeO-EPT is illegal in Singapore [3] and Japan, [4] as ...
5-MeO-DALT is not scheduled at the federal level in the United States, [16] but it is likely that it could be considered an analog of 5-Meo-DiPT, which is a controlled substance in USA, or an analog of another tryptamine, in which case purchase, sale, or possession could be prosecuted under the Federal Analog Act.
5-MeO-DiBF is a psychedelic [1] that has been sold online as a designer drug and was first definitively identified in December 2015 by a forensic laboratory in Slovenia. [2] It is thought to act as an agonist for the 5-HT 1A and 5-HT 2 family of serotonin receptors .